The return of the megamerger

Monday, December 2, 2019 - 01:20 in Mathematics & Economics

Drug companies went on a buying spree in 2019 as they sought to dominate the cancer market and offset competition from generics

Read the whole article on C&EN

More from C&EN

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net